4//SEC Filing
Freeman Kevin Lee 4
Accession 0001562180-25-001551
CIK 0001636422other
Filed
Feb 23, 7:00 PM ET
Accepted
Feb 24, 8:49 PM ET
Size
7.3 KB
Accession
0001562180-25-001551
Insider Transaction Report
Form 4
Freeman Kevin Lee
Chief Commercial Officer
Transactions
- Award
Common Stock
2025-02-20+140,000→ 376,950 total - Award
Common Stock
2025-02-20+18,262→ 395,212 total
Footnotes (2)
- [F1]Represents an award of restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan, 33.33% of the RSUs will vest on December 1, 2025 and, thereafter, the remaining 66.67% of the RSUs will vest in 8 equal quarterly installments.
- [F2]Represents an award of 18,262 performance-based restricted units ("PRSUs") pursuant to the 2019 Plan, based upon the Issuer's satisfaction of certain performance criteria for the fiscal year ended December 31, 2024. Each PRSU represents a contingent right to receive one share of the Issuer's common stock.
Documents
Issuer
Health Catalyst, Inc.
CIK 0001636422
Entity typeother
Related Parties
1- filerCIK 0001945797
Filing Metadata
- Form type
- 4
- Filed
- Feb 23, 7:00 PM ET
- Accepted
- Feb 24, 8:49 PM ET
- Size
- 7.3 KB